ARDT

Ardent Health, Inc. went public in July 2024 with an IPO that raised $192 million. As of May 7, 2026, the closing stock price was $9.90, with a 52-week range between $8.07 and $15.48. In Q1 2026, Ardent Health reported strong financial results, with revenue increasing 7% year-over-year to $1.6 billion and Adjusted EBITDA growing 26%; however, the stock price fell by 3.55% following the announcement due to investor concerns. Analysts have a bullish consensus on ARDT, with a median price target of $13.00 as of May 8, 2026.